Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging - A Retrospective Cross-sectional Study Into Off-label Use of LDN

Authors not listed

AgelessRx · 2022

Deregulated nutrient-sensing Human Randomized controlled trial

Abstract

This retrospective, observational study will assess the health status of short- and long-term low-dose naltrexone (LDN) users.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-07-02 MST

Cite this

APA

Anonymous. (2022). The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging - A Retrospective Cross-sectional Study Into Off-label Use of LDN. <em>AgelessRx</em>. https://clinicaltrials.gov/study/NCT05307627

Vancouver

Anonymous. The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging - A Retrospective Cross-sectional Study Into Off-label Use of LDN. AgelessRx. 2022.

BibTeX

@misc{anon2022TheEff, title = {The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging - A Retrospective Cross-sectional Study Into Off-label Use of LDN}, author = {Anonymous}, journal = {AgelessRx}, year = {2022}, }